MS
51
-7
BAC
35
-6
AXP
50
-9
BBY
33
-4
CTAS
39
-3
HAL
30
-9
MDLZ
46
-4
UHS
54
-8
JNPR
56
-4
AVB
35
-7
C
39
-5
URBN
43
-7
TDC
23
-8
PGR
54
10
LRCX
42
-7
FLS
45
-8
APA
19
-5
ETR
52
-2
BWA
21
-7
CNP
60
-2
MS
51
-7
BAC
35
-6
AXP
50
-9
BBY
33
-4
CTAS
39
-3
HAL
30
-9
MDLZ
46
-4
UHS
54
-8
JNPR
56
-4
AVB
35
-7
C
39
-5
URBN
43
-7
TDC
23
-8
PGR
54
10
LRCX
42
-7
FLS
45
-8
APA
19
-5
ETR
52
-2
BWA
21
-7
CNP
60
-2
Financhill
Back

Sarepta Therapeutics Stock Predictions

Crowdfunding to IPO: Nasdaq's Next Breakout?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sarepta Therapeutics Stock Forecast

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.2% based on the past 27 years of stock performance.
  • Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
  • Is Sarepta Therapeutics Stock Undervalued?
    The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 37.2% based on the past 27 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

  • Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com

52-Week Data

52-Week High:
173.25
52-Week Low:
48.01

Prediction Charts

Market Cap:
4.9B
Price in USD:
50.31
Volume:
2.9M
Beta:
1.09

Technical Analysis

SMA50:
92.51
SMA100:
106.66
SMA200:
121.01
52-Wk Change:
-60.17%

Stock Predictions

  • Is Sarepta Therapeutics stock public?
    Yes, Sarepta Therapeutics is a publicly traded company.
  • What is the Sarepta Therapeutics stock quote today?
    The Sarepta Therapeutics stock price is 50.31 USD today.
  • How to buy Sarepta Therapeutics stock online?
    You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-24 74.67 76.33 76.67 74.44
Mar-25 76.13 73.61 76.26 72.17
Mar-26 73.88 72.88 74.40 70.91
Mar-27 72.98 71.81 73.95 71.25
Mar-28 71.88 70.41 72.05 69.81
Mar-31 65.90 63.82 67.47 62.50
Apr-1 64.37 61.91 65.69 61.53
Apr-2 61.69 62.47 64.23 60.70
Apr-3 57.22 58.61 60.24 57.14
Apr-4 59.22 54.43 59.45 54.26
Apr-7 51.59 52.40 55.17 50.61
Apr-8 53.99 49.30 55.36 48.94
Apr-9 48.55 55.65 57.70 48.01
Apr-10 53.34 50.31 54.47 49.86

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.